Drägerwerk AG & Co. KGaA (DGWPF)
102.31
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Drägerwerk Cash from Investing (Quarterly) : -31.18M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -31.18M |
| March 31, 2026 | -20.99M |
| December 31, 2025 | -25.24M |
| September 30, 2025 | -21.16M |
| June 30, 2025 | -42.64M |
| March 31, 2025 | -25.19M |
| December 31, 2024 | -21.96M |
| September 30, 2024 | -12.57M |
| June 30, 2024 | 7.868M |
| March 31, 2024 | -19.54M |
| December 31, 2023 | -19.85M |
| September 30, 2023 | -13.67M |
| June 30, 2023 | -17.40M |
| March 31, 2023 | -21.81M |
| December 31, 2022 | -22.48M |
| September 30, 2022 | 19.57M |
| June 30, 2022 | 73.67M |
| March 31, 2022 | -33.43M |
| December 31, 2021 | -100.03M |
| September 30, 2021 | -65.82M |
| June 30, 2021 | 12.80M |
| March 31, 2021 | 27.48M |
| December 31, 2020 | -213.07M |
| September 30, 2020 | -41.90M |
| June 30, 2020 | -33.34M |
| Date | Value |
|---|---|
| March 31, 2020 | -20.09M |
| December 31, 2019 | -18.92M |
| September 30, 2019 | -17.42M |
| June 30, 2019 | -18.17M |
| March 31, 2019 | -14.92M |
| December 31, 2018 | -22.17M |
| September 30, 2018 | -17.11M |
| June 30, 2018 | -15.96M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -19.68M |
| September 30, 2017 | -22.67M |
| June 30, 2017 | -19.10M |
| March 31, 2017 | -12.98M |
| December 31, 2016 | -19.05M |
| September 30, 2016 | -18.83M |
| June 30, 2016 | -28.05M |
| March 31, 2016 | -19.14M |
| December 31, 2015 | -28.26M |
| September 30, 2015 | -33.05M |
| June 30, 2015 | -35.61M |
| March 31, 2015 | -89.08M |
| December 31, 2014 | -37.25M |
| September 30, 2014 | -41.84M |
| June 30, 2014 | -32.76M |
| March 31, 2014 | -23.73M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ottobock SE & Co. KGaA | -160.52M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.309M |
| Cash from Financing (Quarterly) | -50.42M |
| Free Cash Flow | 205.02M |
| Free Cash Flow Per Share (Quarterly) | -1.809 |
| Free Cash Flow to Equity (Quarterly) | -217.95M |
| Free Cash Flow to Firm (Quarterly) | -29.40M |
| Free Cash Flow Yield | 10.69% |